Industry Symposium 43 - International Society of Nephrology Events

AshokSarin Moderator India

Session Title: Reimagining Anemia Management in CKD: Evolution with HIF-PHIs

Theme: Preserving Kidney Health

Organized By: Zydus LifeSciences

Session Description:

In recent times, the optimal CKD management has evolved with the advent of HIF-PHIs.

In India, currently, Desidustat is the only HIF-PHI marketed and available for clinical usage. Since its availability, tens of thousands of Indian patients of CKD and identifying the most suitable patient profiles. Newer evidence also suggests a possible role of this new class of drugs beyond anemia

This symposium reviews the evolving role of CKD anemia management in the era of HIF PHIs with Real-World Experience from India.

Learning Objectives:

Understand how HIF-PHIs work and why treatment is shifting from ESAs to HIF-PHIs.
Review key clinical and real-world evidence for Desidustat and other HIF-PHIs.
Apply practical guidance on patient selection, initiation, and monitoring for Desidustat/HIF-PHIs

Time	Session

12:50 13:05	Paradigm Shift in Anemia Management: From ESAs to HIF-PHIs Prem PrakashVarma Speaker India
13:05 13:20	Real World Evidence with Desidustat: India's Contribution to the Global HIF Story DineshKhullar Speaker India
13:20 13:50	Panel discussion - Optimizing Outcomes with HIF-PHIs in CKD Anemia ManishMalik Panel India Narayan Prasad Panel India SandipBhattacharya Panel sandipkb65@gmail.comIndia DibyaSingh Shah Panel Nepal D SBhadauria Panel speaker@doc.comIndia